文献速递眼底病与葡萄膜炎青光眼

体细胞GNAQ突变与一例脉络膜血管瘤中毛细血管畸形的关联

Association of Somatic GNAQ Mutation With Capillary Malformations in a Case of Choroidal Hemangioma.
PubMed 文献 · JAMA Ophthalmol · 2019-01-01

该研究分析一例Sturge-Weber综合征合并脉络膜血管瘤摘除眼标本,用激光捕获微切割分离脉络膜血管并检测GNAQ R183Q突变。患者脉络膜血管突变频率为21.1%,与另一Sturge-Weber综合征患者脑组织25.1%相近,而视网膜母细胞瘤脉络膜血管为0.5%、肺组织为0.2%。结果提示Sturge-Weber综合征中的脉络膜血管瘤更准确的描述为脉络膜毛细血管畸形。

要点

  • Sturge-Weber综合征患者脉络膜血管中检出GNAQ R183Q突变,频率21.1%。
  • 该频率与另一Sturge-Weber综合征患者脑组织的25.1%相近。
  • 结果提示脉络膜血管瘤可能应描述为脉络膜毛细血管畸形。

核心结论

  • Sturge-Weber综合征患者的脉络膜血管瘤中检测到GNAQ R183Q突变,提示其本质可能为脉络膜毛细血管畸形。

研究设计与样本

  • 对一例Sturge-Weber综合征合并脉络膜血管瘤并接受眼球摘除患者的石蜡包埋脉络膜组织,用激光捕获微切割分离血管并提取基因组DNA进行突变分析。
  • 阴性对照为视网膜母细胞瘤眼的脉络膜组织和未受累肺组织,阳性对照为另一Sturge-Weber综合征患者的脑组织,并分析婴儿血管瘤。
  • 通过微滴数字PCR测定GNAQ R183和GNAQ Q209L/H/P突变等位基因频率,并用免疫荧光染色观察婴儿血管瘤标志物葡萄糖转运蛋白-1。

主要发现

  • 患者脉络膜血管中GNAQ R183Q突变频率为21.1%,与另一Sturge-Weber综合征患者脑组织的25.1%相近。
  • 视网膜母细胞瘤眼脉络膜血管该突变为0.5%,肺组织为0.2%。
  • 患者脉络膜组织对3种与先天性血管瘤相关的GNAQ突变及婴儿血管瘤标志物葡萄糖转运蛋白-1均为阴性。

临床怎么用

  • 结果提示Sturge-Weber综合征中的脉络膜血管瘤更准确的描述为脉络膜毛细血管畸形。
  • 该发现可能解释普萘洛尔治疗婴儿血管瘤有效,但在脉络膜血管瘤患者中基本无效。

局限性

  • 作者指出需要进一步研究来证实该发现。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

IMPORTANCE: Choroidal hemangiomas are defined by a thickened choroid owing to vessel overgrowth, which may increase the intraocular pressure and lead to glaucoma. Choroidal hemangioma and glaucoma often co-occur in patients with Sturge-Weber syndrome, a rare neurocutaneous disorder characterized by capillary malformations. OBJECTIVE: To determine whether the mutation found in most capillary malformations, GNAQ R183Q (c.548G>A), was present in the choroidal hemangioma of a patient with Sturge-Weber syndrome. DESIGN, SETTING, AND PARTICIPANT: Using laser-capture microdissection, choroidal blood vessels were isolated from paraffin-embedded tissue sections, and genomic DNA was extracted for mutational analysis. Choroidal sections were analyzed in parallel. A patient with choroidal hemangioma and Sturge-Weber syndrome who had undergone enucleation was analyzed in this study at Boston Children's Hospital. Negative controls were choroidal tissue from an eye with retinoblastoma and unaffected lung tissue; brain tissue from a different patient with Sturge-Weber syndrome served as a positive control. Infantile hemangioma was analyzed as well. Data were analyzed in 2018. MAIN OUTCOMES AND MEASURES: The mutant allelic frequency of GNAQ R183 and GNAQ Q209L/H/P was determined by droplet digital polymerase chain reaction on isolated genomic DNA. The infantile hemangioma marker glucose transporter-1 was visualized by immunofluorescent staining of tissue sections. RESULTS: The GNAQ R183Q mutation was present in the patient's choroidal vessels (21.1%) at a frequency similar to that found in brain tissue from a different patient with Sturge-Weber syndrome (25.1%). In contrast, choroidal vessels from a case of retinoblastoma were negative for the mutation (0.5%), as was lung tissue (0.2%). The patient's choroidal tissue was negative for the 3 GNAQ mutations associated with congenital hemangioma and for the infantile hemangioma marker glucose transporter-1. CONCLUSIONS AND RELEVANCE: The results suggest that a more accurate description for choroidal hemangioma in patients with Sturge-Weber syndrome is choroidal capillary malformation. This finding may explain why propranolol, used to treat infantile hemangiomas, has been largely ineffective in patients with choroidal hemangioma. Further studies are needed to corroborate this finding.

来源:JAMA Ophthalmol,查看原文。版权归原作者所有。

引用

  1. Bichsel CA, Goss J, Alomari M, et al. Association of Somatic GNAQ Mutation With Capillary Malformations in a Case of Choroidal Hemangioma. JAMA Ophthalmol. 2019. PMID: 30422215. doi:10.1001/jamaophthalmol.2018.5141

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。